Hikma Pharmaceutical | HIK - 売上総利益

株価
1,417.50
毎日の変更
7.00 0.50%
毎月
6.86%
毎年
-29.27%
Q2 予測
1,384.20




売上総利益 変化する 日付
Almirall EUR 429.87M 180.02M 2025-12
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Autolus Therapeutics Ltd USD -1.04M 6.41M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Fresenius EUR 1.51B 214M 2025-12
Galapagos EUR 900.37M 913.94M 2025-12
Genmab DKK 977M 13M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
GRIFOLS EUR 686.84M 56.95M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Merck EUR 2.96B 252M 2025-12
Orion EUR 254M 254.7M 2026-03
Recordati EUR 432.41M 8.56M 2025-09
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 3.19B 621M 2025-12